Status:
UNKNOWN
Intervention, Prognosis and Mechanism of Covid-19 Infection in Patients With Underlying Diseases
Lead Sponsor:
The Second Affiliated Hospital of Chongqing Medical University
Conditions:
Chronic Liver Disease
Malignant Tumor
Eligibility:
All Genders
18-100 years
Brief Summary
The goal of this observational study is to explore the influence of Covid-19 infection and risk factors of severe outcomes in vulnerable population including patients with chronic liver disease, malig...
Eligibility Criteria
Inclusion
- Sign the informed consent form before enrollment, and be able to complete the research according to the requirements of the research protocol.
- Enrolled patients need to have basic diseases, including chronic liver disease, chronic kidney disease, chronic lung disease, solid tumors, AIDS, rheumatic immune diseases, diabetes, etc.
- When entering the group, patients with new crowns need to be confirmed by evidence of a positive test for new coronavirus nucleic acid (CT value \<35) or a positive test for new coronavirus antigen.
Exclusion
- Participate in clinical trials of other investigational drugs or medical devices within 3 months before screening, and take experimental drugs or use medical devices.
- Positive pregnancy test during lactation or screening period.
- Subjects who, in the investigator's opinion, have other factors that are not suitable for participating in this study.
Key Trial Info
Start Date :
August 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT05965843
Start Date
August 1 2023
End Date
December 1 2024
Last Update
August 3 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.